Keyphrases
Indomethacin
100%
Transient Receptor Potential Vanilloid 4 (TRPV4)
100%
Intestinal Injury
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
63%
Drug-induced
36%
Knockdown
18%
Transepithelial Electrical Resistance
18%
Drug Use
18%
Knock-in Mouse Model
9%
Epithelium
9%
Protein Expression
9%
Molecular Mechanism
9%
MRNA Expression
9%
Quantitative PCR
9%
Toll-like
9%
Gastrointestinal Bleeding
9%
Antibiotics
9%
WT Mice
9%
Serious Complications
9%
Small Interfering RNA (siRNA)
9%
Gastrointestinal Tract
9%
Intestinal Epithelium
9%
Epoxyeicosatrienoic Acids
9%
Human Tissue
9%
Mouse Tissue
9%
Hyperpermeability
9%
As(V)
9%
Arachidonic Acid Cascade
9%
Initial Damage
9%
New Drug Targets
9%
Intestinal Hyperpermeability
9%
Immunochemistry
9%
Gastrointestinal Ulcer
9%
Methylsulfonyl
9%
Ca2+ Imaging
9%
Intestinal Cell Line
9%
Nonsteroidal Anti-inflammatory Drug-induced Enteropathy
9%
Non-selective Cation Channel
9%
Channel Activity
9%
IEC-6
9%
IEC-6 Cells
9%
Epoxygenase
9%
Pharmacology, Toxicology and Pharmaceutical Science
Indometacin
100%
Vanilloid Receptor 4
100%
Intestine Injury
100%
Non-Steroidal Anti-Inflammatory Drug
72%
Knockout Mouse
9%
Wild Type Mouse
9%
Toll Like Receptor 4
9%
Calcium Ion
9%
Small Interfering RNA
9%
Antibiotics
9%
Gastrointestinal Hemorrhage
9%
Enteropathy
9%
Arachidonic Acid
9%
Cation Channel
9%
Digestive System Ulcer
9%
5,6 Epoxy 8,11,14 Icosatrienoic Acid
9%
Messenger RNA
9%